{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T06:32:22Z","timestamp":1775975542191,"version":"3.50.1"},"reference-count":45,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2004,3,5]],"date-time":"2004-03-05T00:00:00Z","timestamp":1078444800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2004,3,5]]},"abstract":"<jats:title>SUMMARY<\/jats:title><jats:p>Parathyroid hormone (PTH) stimulates osteoblasts to produce the proinflammatory cytokine interleukin-6 (IL-6), causing bone resorption. In patients with primary hyperparathyroidism, elevated serum levels of IL-6 normalize after resection of parathyroid tumours. Because IL-6 is also expressed in normal parathyroids and in other endocrine cells (adrenal and islet), we hypothesized that parathyroid tumours might contribute directly to the elevated serum IL-6 levels in patients with hyperparathyroidism. Immunohistochemistry identified IL-6, PTH, and chromogranin-A (an endocrine and neuroendocrine tumour marker) in normal, adenomatous and hyperplastic parathyroids. Using immunofluorescence and confocal microscopy, IL-6 co-localized with PTH and with chromogranin-A in parathyroid cells. All cultured parathyroid tumours secreted IL-6 at levels markedly higher than optimally stimulated peripheral blood mononuclear cells. Supernates from cultured parathyroids stimulated proliferation of an IL-6-dependent cell line, and anti-IL-6\u2003MoAb abolished this stimulatory effect. IL-6 mRNA was documented in cultured parathyroid tumours, cultured normal parathyroids, fresh operative parathyroid tumours and fresh operative normal specimens. In conclusion, these data show that parathyroid tumours and normal parathyroids contain, produce and secrete IL-6. Our findings present a novel pathway by which human parathyroids may contribute markedly to IL-6 production and elevation of serum IL-6 levels in patients with hyperparathyroidism. The physiological relevance of IL-6 production by human parathyroids remains to be determined, but IL-6 secretion by parathyroid tumours may contribute to bone loss and to other multi-system complaints observed in these patients.<\/jats:p>","DOI":"10.1111\/j.1365-2249.2004.02419.x","type":"journal-article","created":{"date-parts":[[2004,3,18]],"date-time":"2004-03-18T10:17:18Z","timestamp":1079605038000},"page":"145-156","source":"Crossref","is-referenced-by-count":30,"title":["Interleukin-6 production and secretion by human parathyroids"],"prefix":"10.1093","volume":"136","author":[{"given":"S A","family":"SAFLEY","sequence":"first","affiliation":[{"name":"Department of Surgery"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F","family":"VILLINGER","sequence":"additional","affiliation":[{"name":"Department of Pathology, Emory University School of Medicine, Atlanta, Georgia, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E H","family":"JACKSON","sequence":"additional","affiliation":[{"name":"Department of Surgery"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"TUCKER-BURDEN","sequence":"additional","affiliation":[{"name":"Department of Surgery"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"COHEN","sequence":"additional","affiliation":[{"name":"Department of Pathology, Emory University School of Medicine, Atlanta, Georgia, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C J","family":"WEBER","sequence":"additional","affiliation":[{"name":"Department of Surgery"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2004,3,5]]},"reference":[{"key":"2022011223183263000_b1","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/B978-012098651-4\/50022-5","volume-title":"The parathyroids: basic and clinical concepts","author":"Silverberg","year":"2001","edition":"2nd"},{"key":"2022011223183263000_b2","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1056\/NEJM199910213411701","article-title":"A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery","volume":"341","author":"Silverberg","year":"1999","journal-title":"N Engl J Med"},{"key":"2022011223183263000_b3","first-page":"732","article-title":"Marked improvement in bone mass after parathyroidectomy in osteitis fibrosa cystica","volume":"83","author":"Kulak","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2022011223183263000_b4","first-page":"3448","article-title":"Cytokines in primary hyperparathyroidism \u2013 factors that matter [Editorial]","volume":"81","author":"Silverberg","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2022011223183263000_b5","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1172\/JCI118157","article-title":"Adenyl cyclase and interleukin 6 are downstream effectors of parathyroid hormone resulting in stimulation of bone resorption","volume":"96","author":"Greenfield","year":"1995","journal-title":"J Clin Invest"},{"key":"2022011223183263000_b6","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.4049\/jimmunol.145.10.3297","article-title":"IL-6 is produced by osteoblasts and induces bone resporption","volume":"145","author":"Ishimi","year":"1990","journal-title":"J Immunol"},{"key":"2022011223183263000_b7","doi-asserted-by":"crossref","first-page":"4056","DOI":"10.1210\/endo.136.9.7649114","article-title":"Production of interleukin-6 in human osteoblasts and human bone marrow stromal cells: evidence that induction by interleukin-1 and tumor necrosis factor-\u03b1 is not regulated by ovarian steroids","volume":"136","author":"Rifas","year":"1995","journal-title":"Endocrinology"},{"key":"2022011223183263000_b8","first-page":"471","volume-title":"Molecular and cellular biology of cytokines","author":"Horowitz","year":"1990"},{"key":"2022011223183263000_b9","doi-asserted-by":"crossref","first-page":"3850","DOI":"10.1210\/endo.142.9.8368","article-title":"IL-6 negatively regulated IL-11 production in vitro and in vivo","volume":"142","author":"Nakchbandi","year":"2001","journal-title":"Endocrinology"},{"key":"2022011223183263000_b10","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/0006-291X(89)90851-6","article-title":"Parathyroid hormone (PTH) and PTH-like protein (PLP) stimulate interleukin-6 production by osteogenic cells: a possible role of interleukin-6 in osteoclastogenesis","volume":"162","author":"Lowik","year":"1989","journal-title":"Biochem Biophys Res Commun"},{"key":"2022011223183263000_b11","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1002\/jbmr.5650081003","article-title":"Regulation of cytokine expression in osteoblasts by parathyroid hormone: rapid stimulation of interleukin-6 and leukemia inhibitory factor mRNA","volume":"8","author":"Greenfield","year":"1993","journal-title":"J Bone Miner Res"},{"key":"2022011223183263000_b12","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/0006-291X(91)91360-O","article-title":"Effect of parathyroid hormone on release of interleukin-1 and interleukin-6 from cultured mouse osteoblastic cells","volume":"179","author":"Li","year":"1991","journal-title":"Biochem Biophys Res Commun"},{"key":"2022011223183263000_b13","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1002\/jbmr.5650080706","article-title":"Stimulation of interleukin-6 production by either calcitonin gene-related peptide or parathyroid hormone in two phenotypically distinct bone marrow-derived murine stromal cell lines","volume":"8","author":"Sakagami","year":"1993","journal-title":"J Bone Miner Res"},{"key":"2022011223183263000_b14","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1126\/science.1621100","article-title":"Increased osteoclast development after estrogen loss: mediation by interleukin-6","volume":"257","author":"Jilka","year":"1992","journal-title":"Science"},{"key":"2022011223183263000_b15","first-page":"3450","article-title":"Circulating levels of interleukin-6 and tumor necrosis factor-\u03b1 are elevated in primary hyperparathyroidism and correlate with markers of bone resporption \u2212 a clinical research center study","volume":"81","author":"Jacob","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2022011223183263000_b16","first-page":"N108","article-title":"Role of the interleukin-6\/interleukin-6 soluble receptor cytokine system in mediating increased skeletal sensitivity to parathyroid hormone in perimenopausal women","volume":"17","author":"Insogna","year":"2002","journal-title":"J Bone Miner Res"},{"key":"2022011223183263000_b17","doi-asserted-by":"crossref","first-page":"4946","DOI":"10.1210\/jc.2001-011814","article-title":"Circulating levels of interleukin-6 soluble receptor predict rates of bone loss in patients with primary hyperparathyroidism","volume":"87","author":"Nakchbandi","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2022011223183263000_b18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-2776(08)60532-5","article-title":"Interleukin-6 in biology and medicine","volume":"54","author":"Akira","year":"1993","journal-title":"Adv Immunol"},{"key":"2022011223183263000_b19","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1038\/sj.bjc.6690571","article-title":"Expression and up-regulation of interleukin-6 in oesophageal carcinoma cells by n-sodium butyrate","volume":"80","author":"Wang","year":"1999","journal-title":"Br J Cancer"},{"key":"2022011223183263000_b20","first-page":"4403","article-title":"Dexamethasone enhances expression of membrane and soluble interleukin-6 receptors by prostate carcinoma cell lines","volume":"18","author":"Mori","year":"1998","journal-title":"Anticancer Res"},{"key":"2022011223183263000_b21","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/(SICI)1098-1136(199905)26:3<191::AID-GLIA1>3.0.CO;2-#","article-title":"Role of interleukin-6 and soluble IL-6 receptor in region-specific induction of astrocytic differentiation and neurotrophin expression","volume":"26","author":"Heese","year":"1999","journal-title":"Glia"},{"key":"2022011223183263000_b22","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/00000658-199803000-00012","article-title":"Marked elevation of serum interleukin-6 in patients with cholangiocarcinoma","volume":"227","author":"Goydos","year":"1998","journal-title":"Ann Surg"},{"key":"2022011223183263000_b23","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1385\/ENDO:17:2:135","article-title":"Immunohistochemical localization of interleukin-6 in peripheral human endocrine glands","volume":"17","author":"Kontogeorgos","year":"2002","journal-title":"Endocrine"},{"key":"2022011223183263000_b24","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1093\/clinchem\/33.8.1364","article-title":"Highly sensitive two-site immunoradiometric assay of parathyrin, and its clinical utility in evaluating patients with hypercalcemia","volume":"33","author":"Nussbaum","year":"1988","journal-title":"Clin Chem"},{"key":"2022011223183263000_b25","first-page":"22","article-title":"Immune response in hemodialysis patients: is there any difference when low and high iPTH levels are compared?","volume":"54","author":"Tzanno-Martins","year":"2000","journal-title":"Clin Nephrol"},{"key":"2022011223183263000_b26","doi-asserted-by":"crossref","first-page":"S188","DOI":"10.1086\/514283","article-title":"Markedly elevated levels of interferon (IFN)-\u03b3, IFN-\u03b1, interleukin (IL)-2, IL-10, and tumor necrosis factor-\u03b1 asssociated with fatal Ebola virus infection","volume":"178","author":"Villinger","year":"1999","journal-title":"J Infect Dis"},{"key":"2022011223183263000_b27","doi-asserted-by":"crossref","first-page":"3945","DOI":"10.4049\/jimmunol.155.8.3946","article-title":"Comparative analysis of cytokine genes from nonhuman primates","volume":"155","author":"Villinger","year":"1995","journal-title":"J Immunol"},{"key":"2022011223183263000_b28","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/nm0197-80","article-title":"Sterile protection of monkeys against malaria after administration of interleukin-12","volume":"3","author":"Hoffman","year":"1997","journal-title":"Nat Med"},{"key":"2022011223183263000_b29","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/1043-4666(93)90038-7","article-title":"Qualitative and quantitative studies of cytokines synthesized and secreted by non-human primate peripheral blood mononuclear cells","volume":"5","author":"Villinger","year":"1993","journal-title":"Cytokine"},{"key":"2022011223183263000_b30","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1177\/030089168507100216","article-title":"Nonfunctioning parathyroid carcinoma. A case report","volume":"71","author":"Merlano","year":"1985","journal-title":"Tumori"},{"key":"2022011223183263000_b31","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1084\/jem.182.1.243","article-title":"Interleukin 6 is essential for in vivo development of B lineage neoplasm","volume":"182","author":"Hilbert","year":"1995","journal-title":"J Exp Med"},{"key":"2022011223183263000_b32","first-page":"689","article-title":"Defective development of pristane-oil-induced plasmacytomas in interleukin-6-deficient BALB\/c mice","volume":"151","author":"Lattanzio","year":"1997","journal-title":"Am J Pathol"},{"key":"2022011223183263000_b33","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1182\/blood.V74.4.1360.1360","article-title":"Pathogenic significance of interleukin-6 (IL-6\/BSF-2) in Castleman's disease","volume":"74","author":"Yoshizaki","year":"1989","journal-title":"Blood"},{"key":"2022011223183263000_b34","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1056\/NEJM199403033300904","article-title":"Alleviation of systemic manifestation of Castleman's disease by monoclonal anti-interleukin-6 antibody","volume":"330","author":"Beck","year":"1994","journal-title":"N Engl J Med"},{"key":"2022011223183263000_b35","doi-asserted-by":"crossref","first-page":"11924","DOI":"10.1073\/pnas.90.24.11924","article-title":"Soluble interleukin 6 receptor triggers osteoclast formation by interleukin 6","volume":"90","author":"Tamura","year":"1993","journal-title":"Proc Natl Acad Sci"},{"key":"2022011223183263000_b36","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1002\/j.1460-2075.1994.tb06368.x","article-title":"Interleukin 6 deficient mice are protected from bone loss caused by estrogen depletion","volume":"13","author":"Poli","year":"1994","journal-title":"EMBO J"},{"key":"2022011223183263000_b37","first-page":"2032","article-title":"Serum interleukin 6 is a major predictor of bone loss in women specific to the first decade past monopause","volume":"86","author":"Scheidt-Nave","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2022011223183263000_b38","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1084\/jem.187.4.461","article-title":"Interleukin-6 is required for the development of collagen-induced arthritis","volume":"187","author":"Alonzi","year":"1998","journal-title":"J Exp Med"},{"key":"2022011223183263000_b39","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1002\/(SICI)1521-4141(199807)28:07<2178::AID-IMMU2178>3.0.CO;2-D","article-title":"IL-6-deficient mice resist myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis","volume":"28","author":"Eugster","year":"1998","journal-title":"Eur J Immunol"},{"key":"2022011223183263000_b40","doi-asserted-by":"crossref","first-page":"4683","DOI":"10.1210\/endo.140.10.7036","article-title":"A role for interleukin-6 in parathyroid hormone-induced bone resorption in vivo","volume":"140","author":"Grey","year":"1999","journal-title":"Endocrinology"},{"key":"2022011223183263000_b41","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1097\/00000658-199611000-00009","article-title":"Interleukin-6 and the injured patient. Marker of injury or mediator of inflammation?","volume":"224","author":"Biffl","year":"1996","journal-title":"Ann Surg"},{"key":"2022011223183263000_b42","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/B978-012098651-4\/50004-3","volume-title":"The parathyroids: basic and clinical concepts","author":"Kronenberg","year":"2001"},{"key":"2022011223183263000_b43","doi-asserted-by":"crossref","first-page":"S186","DOI":"10.1046\/j.1523-1755.2001.59780186.x","article-title":"Defects in B-cell function and metabolism in uremia: role of parathyroid hormone","volume":"78","author":"Smogorzewski","year":"2001","journal-title":"Kidney Int Suppl"},{"key":"2022011223183263000_b44","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1038\/ki.1990.147","article-title":"Effect of parathyroid hormone on human T cell activation","volume":"37","author":"Klinger","year":"1990","journal-title":"Kidney Int"},{"key":"2022011223183263000_b45","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/ki.1991.186","article-title":"Inhibition of immunoglobulin production by parathyroid hormone. Implications in chronic renal failure","volume":"40","author":"Gaciong","year":"1991","journal-title":"Kidney Int"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2249.2004.02419.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/136\/1\/145\/42146145\/j.1365-2249.2004.02419.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/136\/1\/145\/42146145\/j.1365-2249.2004.02419.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T04:19:20Z","timestamp":1682655560000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/136\/1\/145\/6479150"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3,5]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2004,3,5]]},"published-print":{"date-parts":[[2004,3,5]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2249.2004.02419.x","relation":{},"ISSN":["0009-9104","1365-2249"],"issn-type":[{"value":"0009-9104","type":"print"},{"value":"1365-2249","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2004,4]]},"published":{"date-parts":[[2004,3,5]]}}}